The Enterprise Value as of September 2024 (TTM) for Dyadic International, Inc. (DYAI) is 36.57M

According to Dyadic International, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 36.57M. This represents a change of -16.81% compared to the average of 43.96M of the last 4 quarters.

Dyadic International, Inc. (DYAI) Historical Enterprise Value (quarterly & annually)

How has DYAI Enterprise Value performed in the past?

The mean historical Enterprise Value of Dyadic International, Inc. over the last ten years is 61.11M. The current 36.57M Enterprise Value has changed 5.89% with respect to the historical average. Over the past ten years (40 quarters), DYAI's Enterprise Value was at its highest in in the June 2020 quarter at 226.09M. The Enterprise Value was at its lowest in in the December 2015 quarter at -6613242.64.

Dyadic International, Inc. (DYAI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Dyadic International, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Dyadic International, Inc. (DYAI) Average Enterprise Value

How has DYAI Enterprise Value performed in the past?

The current Enterprise Value of Dyadic International, Inc. (DYAI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Dyadic International, Inc. (DYAI) Enterprise Value vs. Peers

How is DYAI’s Enterprise Value compared to its peers?

Dyadic International, Inc.’s Enterprise Value is greater than Werewolf Therapeutics, Inc. (-5104292.00), less than Edgewise Therapeutics, Inc. (1.55B), less than Decibel Therapeutics, Inc. (96.42M), less than Celcuity Inc. (627.06M), less than C4 Therapeutics, Inc. (428.66M), less than Anebulo Pharmaceuticals, Inc. (49.05M), less than PMV Pharmaceuticals, Inc. (41.69M), greater than AN2 Therapeutics, Inc. (4.27M), less than Eliem Therapeutics, Inc. (326.18M), greater than HCW Biologics Inc. (31.56M), greater than Molecular Partners AG (-9815827.96), less than MediciNova, Inc. (45.91M), less than Champions Oncology, Inc. (74.62M), greater than Cyteir Therapeutics, Inc. (-20511738.00), greater than Forte Biosciences, Inc. (1.13M), less than DiaMedica Therapeutics Inc. (180.82M), greater than Kineta, Inc. (9.56M), greater than Kintara Therapeutics, Inc. (3.04M),

Build a custom stock screener for Dyadic International, Inc. (DYAI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dyadic International, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Dyadic International, Inc. (DYAI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Dyadic International, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.